Cargando…

Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021

IMPORTANCE: Medicaid is the largest payer of substance use disorder treatment in the US and plays a key role in responding to the opioid epidemic. However, as recently as 2017, many state Medicaid programs still did not cover the full continuum of clinically recommended care. OBJECTIVE: To determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoulders, Angela, Andrews, Christina M., Westlake, Melissa A., Abraham, Amanda J., Grogan, Colleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422193/ https://www.ncbi.nlm.nih.gov/pubmed/37566428 http://dx.doi.org/10.1001/jamahealthforum.2023.2502

Ejemplares similares

Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care
por: Abraham, Amanda J., et al.
Publicado: (2022)

Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021
por: Clemans-Cope, Lisa, et al.
Publicado: (2022)

Medicaid Fees and the Medicare Fee Schedule: An Update
por: Norton, Stephen A.
Publicado: (1995)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

The Impact of Medicaid Adoption of the Medicare Fee Schedule
por: Holahan, John, et al.
Publicado: (1993)

Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014
por: Jayawardhana, Jayani, et al.
Publicado: (2018)

Association of Medicaid Expansion With Opioid Overdose Mortality in the United States
por: Kravitz-Wirtz, Nicole, et al.
Publicado: (2020)

Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999–2008
por: Kahende, Jennifer, et al.
Publicado: (2017)

Children's Mental Health Services in Fee-for-Service Medicaid
por: Larson, Mary Jo, et al.
Publicado: (2004)

Association of State Medicaid Expansion With Hospital Community Benefit Spending
por: Kanter, Genevieve P., et al.
Publicado: (2020)

Health Care Use and Spending Among Need-Based Subgroups of Medicare Beneficiaries With Full Medicaid Benefits
por: Kaufman, Brystana G., et al.
Publicado: (2023)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023)

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
por: Zhai, Mike Z., et al.
Publicado: (2022)

Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018
por: Mafi, John N., et al.
Publicado: (2021)

Association Between Medicaid Managed Care Coverage of Substance Use Services and Treatment Utilization
por: Auty, Samantha G., et al.
Publicado: (2022)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

State Medicaid Programs Bring Managed Care Tenets to Fee for Service
por: Keast, Shellie L., et al.
Publicado: (2016)

Association of State Medicaid Expansion With Rate of Uninsured Hospitalizations for Major Cardiovascular Events, 2009-2014
por: Akhabue, Ehimare, et al.
Publicado: (2018)

Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021
por: Roberts, Thomas J., et al.
Publicado: (2023)

Front End Electronics (FEE 2014)
Publicado: (2014)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion
por: Saloner, Brendan, et al.
Publicado: (2018)

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
por: Tilhou, Alyssa Shell, et al.
Publicado: (2022)

Association of Access to Crisis Intervention Teams With County Sociodemographic Characteristics and State Medicaid Policies and Its Implications for a New Mental Health Crisis Lifeline
por: Newton, Helen, et al.
Publicado: (2022)

Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York
por: Alegría, Margarita, et al.
Publicado: (2022)

Association of Medicaid Expansion With Emergency Department Visits by Medical Urgency
por: Giannouchos, Theodoros V., et al.
Publicado: (2022)

Association of Medicaid Expansion With Medicaid Enrollment and Health Care Use Among Older Adults With Low Income and Chronic Condition Limitations
por: McInerney, Melissa, et al.
Publicado: (2022)

Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs
por: Austin, Anna E., et al.
Publicado: (2023)

Changes in Hydroxyurea Use Among Youths Enrolled in Medicaid With Sickle Cell Anemia After 2014 Revision of Clinical Guidelines
por: Reeves, Sarah L., et al.
Publicado: (2023)

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020)

Coverage of genetic therapies for spinal muscular atrophy across fee-for-service Medicaid programs
por: Ballreich, Jeromie, et al.
Publicado: (2022)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022)

Differences in Diabetic Prescription Drug Utilization and Costs Among Patients With Diabetes Enrolled in Colorado Marketplace and Medicaid Plans, 2014-2015
por: Khorrami, Peggah, et al.
Publicado: (2022)

Association of Nonprofit Hospitals’ Charitable Activities With Unreimbursed Medicaid Care After Medicaid Expansion
por: Stoecker, Charles, et al.
Publicado: (2020)

Association Between Assistance With Medicaid Enrollment and Use of Health Care After Incarceration Among Adults With a History of Substance Use
por: Burns, Marguerite E., et al.
Publicado: (2022)

Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse
por: Swartz, James A., et al.
Publicado: (2023)

ELDER ABUSE AND THE OPIOID CRISIS: PERPETRATORS WHO ARE SUBSTANCE USERS
por: Roberto, Karen A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7tt3l0q05p0ob7i8fbq13n65h3